{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-24-000071","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.116749+00:00","generated_at":"2026-05-31T12:19:52.864088+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Establishment Labs Q2 revenue $44.1M, loss narrows; FDA PMA inspection completed","bullets":["Q2 revenue $44.1M vs $48.6M YoY; gross margin improved to 65.6% from 62.3%.","Operating loss $9.3M vs $13.7M loss YoY; adjusted EBITDA loss $4.3M vs $9.3M.","Net loss $17.2M; cash $54.6M, up $14.6M from Dec 2023.","FY2024 revenue guidance reaffirmed $174M-$184M (+5-11% YoY).","FDA completed PMA preapproval inspection July 26; Motiva Implants US approval expected soon."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-24-000071","json":"https://secwatch.observer/filing/0001688757-24-000071.json","markdown":"https://secwatch.observer/filing/0001688757-24-000071.md","text":"https://secwatch.observer/filing/0001688757-24-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/0001688757-24-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000071/esta-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:19:52.864088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}